NCT03186716View on ClinicalTrials.gov

A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 11, 2017

Primary Completion Date

January 25, 2018

Study Completion Date

March 11, 2018

Conditions
Critical Illness
Interventions
DIETARY_SUPPLEMENT

Colostrum

Enteral colostrum 20g/day powdered colostrum to be mixed in with water and given via nasogastric tube q4 hrs.

DIETARY_SUPPLEMENT

Maltodextrin

Control patients will be received enteral formula and maltodextrin mixed in with water and given via nasogastric tube as boluses q 4hrs.

Trial Locations (1)

Unknown

National Nutrition and Food Technology Research Institute, Tehran

All Listed Sponsors
lead

National Nutrition and Food Technology Institute

OTHER

NCT03186716 - A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients | Biotech Hunter | Biotech Hunter